John Concato

Summary

Publications

  1. ncbi Molecular markers and mortality in prostate cancer
    John Concato
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, CT, USA
    BJU Int 100:1259-63. 2007
  2. ncbi Impact of biochemical recurrence in prostate cancer among US veterans
    Edward M Uchio
    Surgical Urology and Medical Service, VA Clinical Epidemiology Research Center, VA Connecticut Healthcare System, 950 Campbell Ave, 151B, West Haven, CT 06516, USA
    Arch Intern Med 170:1390-5. 2010
  3. ncbi Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores
    Carlos A Vaz Fragoso
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut 06516, USA
    J Am Geriatr Soc 59:1847-54. 2011
  4. ncbi Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons
    Carlos A Vaz Fragoso
    Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
    Respir Care 56:1771-7. 2011
  5. ncbi Observational methods in comparative effectiveness research
    John Concato
    VA Clinical Epidemiology Research Center and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Am J Med 123:e16-23. 2010
  6. ncbi Molecular markers and death from prostate cancer
    John Concato
    Veterans Affairs Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Ann Intern Med 150:595-603. 2009
  7. ncbi Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis
    Carlos A Vaz Fragoso
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, 950 Campbell Ave, Mailcode 151B, West Haven, CT, USA
    Eur Respir J 40:37-44. 2012
  8. ncbi Changes in Gleason scores for prostate cancer: what should we expect from a measurement?
    Jorge Ramos
    Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Investig Med 58:625-8. 2010
  9. ncbi Respiratory impairment and mortality in older persons: a novel spirometric approach
    Carlos A Vaz Fragoso
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
    J Investig Med 59:1089-95. 2011
  10. ncbi To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting
    Vinita Parkash
    Dept of Pathology, Yale University School of Medicine, New Haven, CT, USA
    Am J Clin Pathol 134:42-9. 2010

Collaborators

Detail Information

Publications21

  1. ncbi Molecular markers and mortality in prostate cancer
    John Concato
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, CT, USA
    BJU Int 100:1259-63. 2007
    ..g. markers of cell-cycle regulation), in addition to the effect of traditional clinical factors (e.g. anatomical stage, histological grade), in predicting long-term mortality among men newly diagnosed with prostate cancer...
  2. ncbi Impact of biochemical recurrence in prostate cancer among US veterans
    Edward M Uchio
    Surgical Urology and Medical Service, VA Clinical Epidemiology Research Center, VA Connecticut Healthcare System, 950 Campbell Ave, 151B, West Haven, CT 06516, USA
    Arch Intern Med 170:1390-5. 2010
    ..The impact of BCR on subsequent mortality is uncertain, however, especially given competing causes of death...
  3. ncbi Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores
    Carlos A Vaz Fragoso
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, Connecticut 06516, USA
    J Am Geriatr Soc 59:1847-54. 2011
    ..The current study has therefore evaluated the association between LMS-staged COPD and health outcomes, in two separate cohorts of older persons...
  4. ncbi Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons
    Carlos A Vaz Fragoso
    Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
    Respir Care 56:1771-7. 2011
    ..Evidence is limited, however, on whether the LMS method is valid for evaluating respiratory impairment in middle-aged persons...
  5. ncbi Observational methods in comparative effectiveness research
    John Concato
    VA Clinical Epidemiology Research Center and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Am J Med 123:e16-23. 2010
    ....
  6. ncbi Molecular markers and death from prostate cancer
    John Concato
    Veterans Affairs Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Ann Intern Med 150:595-603. 2009
    ..Current methods to assess the prognosis of prostate cancer at the time of diagnosis are limited...
  7. ncbi Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis
    Carlos A Vaz Fragoso
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, 950 Campbell Ave, Mailcode 151B, West Haven, CT, USA
    Eur Respir J 40:37-44. 2012
    ..32)). In older white persons, LMS-defined respiratory impairment is strongly associated with an increased risk of COPD hospitalisation. These results support the LMS method as a basis for defining respiratory impairment in older persons...
  8. ncbi Changes in Gleason scores for prostate cancer: what should we expect from a measurement?
    Jorge Ramos
    Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Investig Med 58:625-8. 2010
    ..An upward shift has occurred in the distribution of Gleason scores during the past decade; this change was influenced by reports suggesting that lower scores (range, 2-4) should not be assigned to biopsy specimens...
  9. ncbi Respiratory impairment and mortality in older persons: a novel spirometric approach
    Carlos A Vaz Fragoso
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
    J Investig Med 59:1089-95. 2011
    ....
  10. ncbi To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting
    Vinita Parkash
    Dept of Pathology, Yale University School of Medicine, New Haven, CT, USA
    Am J Clin Pathol 134:42-9. 2010
    ..6, which could be clinically significant when the count approaches the set minimum. Uniform criteria are necessary to allow for meaningful comparisons between studies on minimal nodal counts for cancer lymphadenectomies...
  11. ncbi Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy
    Herta H Chao
    VA Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Investig Med 58:566-8. 2010
    ..Our objective was to determine the proportion of men with castrate-resistant prostate cancer (CRPC) in a clinical setting that would have been excluded from major phase 3 RCTs...
  12. ncbi Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death
    Neomi A Shah
    Yale Center for Sleep Medicine, New Haven, CT, USA
    Sleep Breath 14:131-6. 2010
    ..This study aims to determine whether obstructive sleep apnea independently increases the risk of coronary events, including death from cardiovascular causes...
  13. ncbi What will the emperor say? Screening for prostate cancer as of 2008
    John Concato
    Veterans Affairs VA Clinical Epidemiology Research Center CERC, VA Connecticut Healthcare System, West Haven, CT, USA
    Cancer J 15:7-12. 2009
    ..As of 2008, the need to counsel patients regarding the possible benefits and harms that can result from screening for (and treating) prostate cancer remains justified...
  14. ncbi Prostate-specific antigen 'velocity' as a diagnostic test for prostate cancer
    John Concato
    Department of Medicine, Clinical Epidemiology Research Center, VA Connecticut Healthcare System, New Haven 06516, USA
    J Investig Med 54:361-4. 2006
    ..Accordingly, we evaluated the sensitivity of prostate-specific antigen (PSA) velocity among men who are diagnosed subsequently with prostate cancer...
  15. ncbi Acetylcholinesterase activity in veterans of the first Gulf War
    John Concato
    VA Connecticut Healthcare System, Clinical Epidemiology Research Center, West Haven, CT 06516, USA
    J Investig Med 55:360-7. 2007
    ..This study was designed to examine relationships of deployment to the Gulf, as well as symptoms after military service, with postdeployment activity of acetylcholinesterase (AChE) and related enzymes...
  16. ncbi Dietary fish or seafood consumption is not related to cerebrovascular disease risk in twin veterans
    Dawn M Bravata
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, CN 06516, USA
    Neuroepidemiology 28:186-90. 2007
    ..The results of studies about dietary fish consumption and stroke risk have been conflicting. We sought to examine the relationship between dietary fish and seafood consumption and the risk of stroke or transient ischemic attack (TIA)...
  17. ncbi Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening?
    Neel R Gandhi
    Robert Wood Johnson Clinical Scholars Program and Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    Med Care 45:1105-9. 2007
    ..Others argue that delays will persist until routine screening is adopted. The Veterans Health Administration (VA) is a unique laboratory to examine whether access to comprehensive health benefits results in earlier entry into HIV care...
  18. ncbi Reporting of multivariable methods in the medical literature
    Jeanette M Tetrault
    Veterans Affairs Clinical Epidemiology Research Center, 950 Campbell Avenue, West Haven, CT 06516, USA
    J Investig Med 56:954-7. 2008
    ....
  19. ncbi Comparative effectiveness research: what kind of studies do we need?
    John Concato
    Clinical Epidemiology Research Center, Veterans Affairs VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Investig Med 58:764-9. 2010
    ..A review of these (and other) selected projects, based on their type of study design, serves to highlight the strengths, limitations, and potential of CER...
  20. ncbi The effectiveness of screening for prostate cancer: a nested case-control study
    John Concato
    Clinical Epidemiology Research Center and Cooperative Studies Program Coordinating Center, Department of Veterans Affairs Connecticut Healthcare System, West Haven Veterans Affairs Medical Center 06516, USA
    Arch Intern Med 166:38-43. 2006
    ..Evidence is lacking, however, to confirm a survival benefit among screened patients. We evaluated the effectiveness of PSA, with or without DRE, in reducing mortality...
  21. ncbi Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis
    Steven B Zeliadt
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
    Cancer 98:496-503. 2003
    ..Further research is needed to identify the reasons for the racial disparity in PSA surveillance and to design interventions to lessen these differences...